A novel biophysical screening method successfully identified 17 fragment hits against the E. coli TPP riboswitch thiM, providing a basis for structure-guided elaboration and a new in vitro functional assay.
May inform antimicrobial development; leaves open clinical relevance pending optimization and in vivo testing.
Riboswitches are regions of mRNA that bind selectively certain metabolites, thereby regulating gene expression. We have developed a method, which uses a combination of biophysical techniques (equilibrium dialysis, waterLOGSY and T2 relaxation-edited NMR spectroscopy and isothermal titration calorimetry) that allows screening and identification of novel ligands for riboswitches. By this method a library of 1300 fragments was screened on the E. colithiamine pyrophosphate (TPP) riboswitchthiM, resulting in the identification of 17 hits. The compounds showed KD values from 22 to 670 μM, with four compounds having KD values <100 μM. The fragments are structurally diverse and their ligand efficiency indicates good prospects for structure-guided elaboration. In addition, a riboswitch functional assay based on in vitrotranscription translation (IVTT) of the reporter gene luciferase was developed. This assay system is an alternative to in vivo assays and constitutes a valuable tool to determine the effect of small molecules on riboswitch-regulated gene expression.
No takes yet. Share an insight, caveat, or question.
Cressina et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: